MD · US market
PEDIATRIX MEDICAL GROUP INC COM
Compare this company’s P/E and P/S using trailing results and the latest quarter. Ratios are calculated here from market capitalisation, signed ordinary or common-shareholder earnings and revenue.
Market cap US$2.09bnFinancials dated 30 June 2026Price dated 1 October 2026
Core valuation
Calculation inputs
- Trailing earnings
- US$174.81m
- Latest-quarter run-rate earnings
- US$159.37m
- Latest fiscal-year earnings
- US$165.39m
- Trailing revenue
- US$1.95bn
- Latest-quarter run-rate revenue
- US$1.95bn
- Latest fiscal-year revenue
- US$1.91bn
Featured ETF and mutual-fund exposure
These public funds report this company in their latest disclosed holdings.
- RKSAX · Rockefeller US Small Cap Core Fund Class A2.93% weight · Holdings dated 31 May 2026
- NSCFX · Nuveen Small-Cap Value Opportunities Fund Class R61.86% weight · Holdings dated 30 June 2026
- FSHCX · Fidelity Select Health Care Services Portfolio1.86% weight · Holdings dated 31 May 2026
- XHS · State Street SPDR S&P Health Care Services ETF1.81% weight · Holdings dated 19 August 2026
- LRSVX · Lord Abbett Small Cap Value Fund Class R61.34% weight · Holdings dated 31 May 2026
- SSGSX · Victory Sycamore Small Company Opportunity Fund Class A1.22% weight · Holdings dated 30 June 2026
- PSCH · Invesco S&P SmallCap Health Care ETF0.97% weight · Holdings dated 31 May 2026
- AFDZX · Applied Finance Explorer Fund Institutional Shares0.93% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 163 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- ASVGX · American Century Small Cap Value Fund R5 Class0.93% weight · Holdings dated 30 June 2026
- XSVM · Invesco S&P SmallCap Value with Momentum ETF0.78% weight · Holdings dated 19 August 2026
Sources and limitations
Financial inputs are attributed to SEC EDGAR. Market cap is calculated locally where auditable price and share inputs are available. Missing data stays missing; losses are retained as signed values and produce a numeric signed P/E.
Open financial sourceFinancials as of 30 June 2026. Informational research, not investment advice.